Cutaneous adverse events: a predictor of tumour response under anti-PD-1 therapy for metastatic melanoma, a cohort analysis of 189 patients.

L BottlaenderMona Amini-AdleD Maucort-BoulchP RobinsonLuc ThomasS Dalle

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2020)

Cutaneous AEs are frequent and often manageable toxicity and were a predictor of tumour response in melanoma patients under anti-PD-1 therapy in this cohort.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
oxidative stress
stem cells
patient reported outcomes